AMLX Form 144: 17,105 RSU Shares Vesting

AMLX Form 144 notice reports proposed transfer related to the vesting of restricted stock units into Common stock.

Rhea-AI Filing Summary

AMLX Form 144 notice reports proposed transfer related to the vesting of restricted stock units into Common stock. The filing lists 17,105 shares associated with 03/02/2026 and records a sale of 6,580 Common shares by Camille L Bedrosian on 12/01/2025.

Insights

Securities Compliance Lawyer

Form 144 documents a proposed disposition tied to RSU vesting and a prior sale by an individual.

The notice lists 17,105 Common shares linked to RSU vesting dated 03/02/2026, which reflects a planned transfer rather than an immediate open-market sale.

It also records a previous sale of 6,580 shares by Camille L Bedrosian on 12/01/2025; timing and execution method for the 03/02/2026 shares are not detailed in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AMLX's Form 144 report say?

It reports a proposed transfer of 17,105 Common shares tied to RSU vesting on 03/02/2026. The form also notes a prior sale of 6,580 Common shares by Camille L Bedrosian on 12/01/2025; transaction mechanics for the 03/02/2026 shares are not included.

Who is the broker or filer listed on the AMLX Form 144?

Morgan Stanley Smith Barney LLC is listed as the broker/filer with an address on 1 New York Plaza. The excerpt identifies the broker name and address but does not add further broker instructions or execution details for the planned transfer.

Does the filing confirm an open-market sale for AMLX shares on 03/02/2026?

The filing shows vesting of RSUs converting to 17,105 Common shares on 03/02/2026, not an explicit open-market sale. The excerpt does not specify sale method, proceeds, or timing of any disposal related to those shares.

What insider activity is recorded for AMLX in the past three months?

The excerpt records a sale of 6,580 Common shares by Camille L Bedrosian on 12/01/2025. This is presented as a prior sale; the Form 144 also lists the separate 03/02/2026 RSU vesting amount of 17,105 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 04:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001326969
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Amylyx Pharmaceuticals, Inc.
SEC File Number	001-41199
Address of Issuer	55 Cambridge Parkway Suite 6W Cambridge MASSACHUSETTS 02142
Phone	617-682-0917
Name of Person for Whose Account the Securities are To Be Sold	Bedrosian Camille L
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza 8th Floor New York NY 10004	6461	94205	169295	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2026	Vesting of Restricted Stock Units	Issuer			17105	03/02/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Bedrosian Camille L 55 Cambridge Parkway Suite 6W Cambridge MA 02142	Common	12/01/2025	6580	94419

144: Remarks and Signature

Remarks	This sale represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
Date of Notice	03/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua B. Cohen, as Attorney in Fact
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)